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ABSTRACT 
A stent fracture combined with a coronary artery aneurysm is a rare event. As these events can lead to a harmful 
outcome, such as the development of myocardial ischemia by in-stent restenosis or thrombosis, repeated coronary 
intervention may be required. We report a case of a stent fracture combined with a coronary artery aneurysm. 
The fracture was thought to have developed by mechanical stress produced from a change of regional wall motion 
after an anteroseptal myocardial infarction. As detected by the use of intravascular ultrasound, neither in-stent 
restenosis nor a thrombus in the fractured stent was present. A cardiac magnetic resonance image showed that no 
viable myocardium in the anteroseptal wall was present. Therefore, the patient underwent medical treatment 
without intervention of the fractured stent. (Korean Circ J 2008;38:69-71) 
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Introduction 
 
The use of drug-eluting stents (DES) has reduced 
in-stent restenosis by inhibiting neointimal hyperplasia. 
The use of DES has been applied widely as an effective 
interventional therapeutic modality in coronary artery 
disease. However, complications such as restenosis or a 
stent thrombosis remain in this era of using DES. Re-
cently, stent fractures and coronary artery aneurysms 
after the implantation of a drug-eluting stent have 
emerged as novel complications as these occurrences 
may cause restenosis or a thrombosis. We report here a 
case of stent fracture combined with coronary aneurysm 
after percutaneous coronary intervention (PCI) with a 
drug-eluting stent. 
 
Case  
 
A 70 year-old woman was admitted to the hospital 
with effort angina. Coronary angiography revealed dif-
fuse and significant stenosis in the proximal and mid 
portion of the left anterior descending artery (LAD) 
(Fig. 1A). The LAD lesion was treated with two over-
lapping 3.5×23 mm and 3.0×33 mm sirolimus-
eluting stents (SES; Cypher®, Cordis, Miami Lakes, FL 
USA). Final angiography showed the presence of well-
deployed stents without residual stenosis or dissection. 
However, the big septal artery was jailed with throm-
bolysis in myocardial infarction (TIMI) 0 distal flow 
(Fig. 1B). Although we attempted to wire the jailed 
artery, wiring failed as the artery was below the over-
lapping site and the lesion was tight. The day after the 
PCI, the level of a cardiac biomarker, the creatinine 
kinase MB fraction, increased to 114 ng/mL and echo-
cardiography revealed akinetic regional wall motion 
abnormality at the anteroseptum from the mid to the 
apex. Sixteen months later, the patient suffered from 
resting chest discomfort again and underwent coronary 
angiography. There was complete stent fracture combin-
ed with a coronary artery aneurysm, but no signi-
ficant in-stent restenosis (Fig. 1C and D). Intravascular 
ultrasound (IVUS) confirmed the discontinuation 
of the stent strut and an aneurysmal change (Fig. 2). 
A cardiac magnetic resonance image (MRI) showed the 
presence of myocardial thinning with transmural 
delayed hyperenhancement and akinetic motion on 
the anteroseptal segement (Fig. 3). We concluded that 
the symptom was not associated with the stent fracture 
or the coronary artery aneurysm as previously placed 
stents were patent and the anteroseptal myocardial 
wall was not viable. Therefore, we decided to continue 
clinical surveillance. Six months later, the patient is 
receiving follow-up and has been without symptoms. 
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Discussion 
 
DES have been used widely for the effectiveness about 
restenosis. However, recently a few cases concerning 
the fracture of DES and stent related aneurysms have 
been reported. These occurrences may be considerable 
complications because of the association with restenosis 
or stent thrombosis.1-6) 
Although the cause and pathophysiology of both 
complications are not known, most cases have occurred 
when there are higher radial forces, usage of longer 
stents or the use of overlapping stents.7) These events 
typically occur in a hypermobile and tortuous vessel, 
especially the right coronary artery.8) Overexpansion of 
the stent can be another risk factor as it may weaken 
struts and promote the fracture. Coronary artery aneu-
rysms might result from local hypersensitivity vasculitis 
in response to the polymer or coating drug on the 
DES.9) 
In our case, the big septal artery was occluded totally 
after sirolimus-eluting stent implantation, resulting in 
akinetic motion on the anteroseptal wall. The change 
of regional wall motion might have developed a new 
hinge in the overlapping long stents during the cardiac 
cycle. Thus, mechanical stress on overlapping stents 
could provoke the fracture of the sirolimus-eluting stents. 
The coronary artery aneurysm of this case was ob-
served at a fractured segment in the overlapping stents. 
Mechanical irritation of fractured struts may have 
caused aneurysmal dilation of the coronary vessel, and 
a local hypersensitivity reaction may be attributable to 
the coronary aneurysm. 
Unfortunately, the natural history of DES fracture 
and coronary artery aneurysm has not yet been de-
Fig. 1. Serial findings of coronary angiogram. A: initial coronary angiography showed diffuse stenosis in the proximal and mid portions of
the LAD. B: post PCI angiography revealed well-deployed overlapping SESs, but the big septal artery (arrow) was totally occluded. C:
fluoroscopy at follow-up showed a complete SES fracture. D: coronary angiography showed coronary artery aneurysm (arrowhead) at
the fractured site. LAD: left anterior descending artery, PCI: percutaneous coronary intervention, SES: sirolimus-eluting stent. 
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fined. Moreover, the best treatment for the problems is 
unknown. In our case, there was restenosis or throm-
bosis was not present at the fractured stent. Cardiac 
MRI was performed to formulate the management plan 
because the anteroseptal wall was already akinetic as 
determined by previous echocardiography. Consider-
ing the absence of a viable portion in the anteroseptal 
wall as seen on cardiac MRI and the relative small sized 
coronary aneurysm, we decided to continue clinical 
follow-up instead of performing an interventional pro-
cedure on the LAD lesion. 
Studies about DES fractures and coronary aneurysms 
are still very limited, but physicians should be con-
cerned as these complications can be associated with 
restenosis or a thrombosis. A further investigation is 
needed to define the clinical significance of a DES frac-
ture and coronary artery aneurysm. 
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Fig. 2. IVUS at follow-up angiography confirmed a complete stent fracture with coronary artery aneurysm (arrow heads). IVUS: intravas-
cular ultrasound. 
Fig. 3. Cardiac MRI revealed myocardial thinning with transmural
delayed hyperenhancement (arrow) on the anteroseptal area. 
